Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:venetoclax
|
| gptkbp:approvalYear |
2016
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L01XX52
|
| gptkbp:brand |
gptkb:Venclexta
|
| gptkbp:CASNumber |
1257044-40-8
|
| gptkbp:chemicalFormula |
C45H50ClN7O7S
|
| gptkbp:developer |
gptkb:AbbVie
gptkb:Genentech |
| https://www.w3.org/2000/01/rdf-schema#label |
Venclyxto
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
BCL-2 inhibitor
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:prescriptionStatus |
Rx-only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
nausea diarrhea infections neutropenia |
| gptkbp:usedFor |
gptkb:small_lymphocytic_lymphoma
gptkb:acute_myeloid_leukemia chronic lymphocytic leukemia |
| gptkbp:bfsParent |
gptkb:Venclexta
|
| gptkbp:bfsLayer |
7
|